SV Biotech Crossover Opportunities Fund Discloses 7.0% Stake in TRex Bio
The fund acquired 957,143 shares in TRex Bio’s Oct. 8 IPO and received 963,524 preferred shares upon their conversion at the Oct. 13 closing.
The fund acquired 957,143 shares in TRex Bio’s Oct. 8 IPO and received 963,524 preferred shares upon their conversion at the Oct. 13 closing.